|
|
|
|
|
Legal status
Patent revoked (after opposition at EPO)
| (51) | INT.CL. | A61K 31/505 | (2006.01) |
| A61P 3/06 | (2006.01) |
| (11) | Number of the document | 1339409 |
| (13) | Kind of document | T |
| (96) | European patent application number | 01982623.9 |
| Date of filing the European patent application | 2001-11-16 | |
| (97) | Date of publication of the European application | 2003-09-03 |
| (45) | Date of publication and mention of the grant of the patent | 2008-05-07 |
| (46) | Date of publication of the claims translation | 2008-08-25 |
| (86) | Number | PCT/GB2001/005041 |
| Date | 2001-11-16 |
| (87) | Number | WO 2002/041895 |
| Date | 2002-05-30 |
| (30) | Number | Date | Country code |
| 0028429 | 2000-11-22 | GB |
| (72) |
RAZA, Ali, GB
HUTCHINSON, Howard Gerard, US
|
| (73) |
AstraZeneca AB,
151 85 Södertälje,
SE
|
| (74) |
Liudmila GERASIMOVIČ,
IĮ "Liudmila Gerasimovič, Patentinis patikėtinis", Vingrių g. 13-42, LT-01141 Vilnius,
LT
|
| (54) | Rozuvastatino (ZD-4522) panaudojimas gydant heterozigotinę šeiminę hipercholesterolemiją |
| USE OF ROSUVASTATIN (ZD-4522) IN THE TREATMENT OF HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA |
| Payment date | Validity (years) | Amount | |
| 2013-10-25 | 13 | 1000.00 LTL |
| Patent revoked (after opposition at EPO) | ||
| Invalidation date | 2014-10-06 |